National Registry and Cohort Study of Pulmonary Vascular Disease
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,000
- 试验地点
- 13
- 主要终点
- All-cause Death
研究概览
简要总结
This is a observational、multicenter, prospective cohort study for patients with pulmonary hypertension (PH). The purposes of this study were to evaluate the etiology、clinical characteristics、treatment modalities, and outcomes of patients with PH；also to set up registration system of PH in China, to build a database of Chinese PH, to establish a web-based international standard data acquisition system for PH and a multicenter clinical research platform. The results of the study will provide a basis for the future national health policy for prevention and treatment of PH.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Newly diagnosed or previously diagnosed patients with PH.
- •Documentation of mean pulmonary arterial pressure (mPAP) >20 mm Hg by right heart catheterization, performed at any time prior to study enrollment.
排除标准
- •Have not had documentation of hemodynamic criteria for PH by right heart catheterization at some time preceding study entry and following development of symptoms associated with PH.
- •Do not meet the required hemodynamic criteria for entry into the study.
结局指标
主要结局
All-cause Death
时间窗: 5 years
次要结局
- Number of Participants with Clinical Worsening(5 years)
研究者
Shaoliang Chen, MD
Vice President of Nanjing First Hospital, Director of Cardiovascular Department
Nanjing First Hospital, Nanjing Medical University